GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Mediclinic International PLC (OTCPK:ANHGY) » Definitions » Valuation Rank

Mediclinic International (Mediclinic International) Valuation Rank


View and export this data going back to 2016. Start your Free Trial

What is Mediclinic International Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.


Mediclinic International Valuation Rank Related Terms

Thank you for viewing the detailed overview of Mediclinic International's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


Mediclinic International (Mediclinic International) Business Description

Traded in Other Exchanges
N/A
Address
65 Gresham Street, 6th Floor, London, GBR, EC2V 7NQ
Mediclinic International PLC is a UK based international private healthcare group. It is engaged in offering acute care, specialist-orientated and multi-disciplinary healthcare services, by operating many hospitals and clinics. The geographic operating segments of the company are Mediclinic Southern Africa, Mediclinic Switzerland, and Mediclinic Middle East. It derives the majority of the revenue from the Switzerland segment. The other non-operating segments of the company are the United Kingdom and Corporate. The group's operations are carried out under the Mediclinic and Hirslanden brand.